effect of Fennelin on primary dysmenorrhoea

Phase 2

• Conditions: Primary dysmenorrhea.; Primary dysmenorrhea; N94.4

• Registration Number: IRCT20220512054829N2
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Regular menstruation
Moderate and severe dysmenorrhea
Age between 15-30

Exclusion Criteria

People with underlying diseases
User of other drugs
genital diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Moderate to severe dysmenorrhoea according to Andresh and Milsom questionnaire. Timepoint: Examination of the severity of dysmenorrhea at the beginning of the study before the intervention and on the 1st, 2nd, 3rd and 4th day of menstruation after the intervention. Method of measurement: Andres and Milsom questionnaire.

Secondary Outcome Measures

Name	Time	Method
ausea with dysmenorrhea. Timepoint: At the beginning of drug use and days 1, 2, 3, and 4 of dysmenorrhea in two consecutive menstrual periods. Method of measurement: Andrash and Milsom questionnaire.;Vomiting with dysmenorrhea. Timepoint: At the beginning of drug use and days 1, 2, 3, and 4 of dysmenorrhea in two consecutive menstrual periods. Method of measurement: Andrash and Milsom questionnaire.;Back pain with dysmenorrhea. Timepoint: At the beginning of drug use and days 1, 2, 3, and 4 of dysmenorrhea in two consecutive menstrual periods. Method of measurement: Andrash and Milsom questionnaire.